Robert Noreck - Mar 20, 2023 Form 4 Insider Report for BRIGHTCOVE INC (BCOV)

Role
Chief Financial Officer
Signature
/s/ Christopher Keenan, as attorney-in-fact
Stock symbol
BCOV
Transactions as of
Mar 20, 2023
Transactions value $
$0
Form type
4
Date filed
3/21/2023, 04:15 PM
Previous filing
Dec 12, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCOV Common Stock Award $0 +70.2K +39.8% $0.00 247K Mar 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCOV Premium-Priced Stock Option (right to buy) Award $0 +171K $0.00 171K Mar 20, 2023 Common Stock 171K $7.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired pursuant to a restricted stock unit award under the Brightcove Inc. 2021 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Brightcove Inc. common stock. The restricted stock units vest in three equal annual installments beginning on March 10, 2024.
F2 This premium-priced stock option has an exercise price of $7.00 and will therefore only have value if the Issuer's stock price appreciates by at least 59% from the closing stock price on the date of grant.
F3 This premium-priced stock option vests in three equal annual installments beginning on March 10, 2024.